Cite
HARVARD Citation
Hellings, P. et al. (n.d.). A new allergic rhinitis therapy (MP29‐02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies. Clinical and translational allergy. 5 (4), p. n/a. [Online].